Reports: The Health Funds (Estonia): Difference between revisions

From Beacon
No edit summary
No edit summary
Line 13: Line 13:


'''Access to information:''' [https://www.tervisekassa.ee/tervisekassa/finantsaruanded-ja-eelarve Click here to access].
'''Access to information:''' [https://www.tervisekassa.ee/tervisekassa/finantsaruanded-ja-eelarve Click here to access].
{{Esophagus}}
{{Stomach}}
{{Small intestine}}
{{Large intestine}}
{{Rectum}}
{{Anus}}
{{Liver}}
{{Gallbladder}}
{{Bile ducts}}
{{Pancreas}}
{{Colon}}
{{Lung}}
{{Trachea}}
{{Bronchi}}
{{Pleura}}
{{Mediastinum}}
{{Vulva}}
{{Vagina}}
{{Cervix}}
{{Uterus}}
{{Ovary}}
{{Fallopian tubes}}
{{Endometrium}}
{{Lobular}}
{{Breast}}
{{Nipple}}
{{Areola}}
{{Ductal}}

Revision as of 20:04, 10 September 2024

Go back to Estonia page

Primary purpose: To outline the vision, mission, and strategic goals of the Health Insurance Fund in Estonia, focusing on ensuring the availability of health insurance benefits and improving healthcare services through prevention, early intervention, and better-coordinated treatment.

Sponsor, manager or home institution: Tervisekassa.

Type of information: healthcare costs; Medicine costs; Costs of disease prevention; Cancer screening costs; total health costs in general. Click here to learn more.

Data level: national level.

Cancer areas of interest: C15-C26: Digestive system cancers; C30-C39: Lung/chest cancers; C51-C58: Female genitalia cancer; C50: Breast cancer. Click here to learn more.

Access to information: Click here to access.